Apoptosis, Oxidative Stress, and Cell Cycle Disruption: Antitumor Effects of a Novel Palladium(II) Complexes

Area of Science:

• Oncology
• Medicinal Chemistry
• Molecular Biology

Background:

• Developing metal-based anticancer agents with improved selectivity and reduced toxicity is crucial in cancer therapy.
• Palladium(II) complexes are explored for their cytotoxic potential against various cancer types.

Purpose of the Study:

• To synthesize and evaluate novel palladium(II) complexes for their anticancer activity against breast cancer cell lines.
• To investigate the mechanisms of action, including cell cycle arrest, oxidative stress, and apoptosis induction, of the most potent complex.

Main Methods:

• Cytotoxicity assays were performed on MCF-7 and MDA-MB-231 breast cancer cell lines using four palladium(II) complexes and cisplatin as a reference.
• Flow cytometry was employed to analyze cell cycle distribution and apoptosis.
• Reactive oxygen species (ROS) detection assays and mitochondrial membrane potential measurements were conducted.
• Western blotting or activity assays were used to assess caspase activation.

Main Results:

• Complexes 1a, 1b, and 2a exhibited significant cytotoxicity, with complex 2a showing potent activity against MCF-7 cells.
• Complex 2a induced S-phase arrest in MCF-7 cells and G2/M phase arrest in MDA-MB-231 cells.
• Treatment with complex 2a led to increased oxidative stress, loss of mitochondrial membrane potential, and activation of both intrinsic (caspase-9) and extrinsic (caspase-8) apoptotic pathways, culminating in caspase-3 and -7 activation.

Conclusions:

• Palladium(II) complex 2a displays potent and multifaceted anticancer activity against breast cancer cells.
• The observed effects are mediated through cell cycle arrest, induction of oxidative stress, and activation of apoptosis.
• Complex 2a represents a promising scaffold for the development of novel palladium-based chemotherapeutics for breast cancer treatment.